LYKA LABS
Back to Balance Sheet
|
LYKA LABS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹54 Cr | ₹47 Cr | ₹38 Cr | ₹33 Cr | ₹99 Cr |
What is the latest Total Current Liabilities ratio of LYKA LABS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2026 | ₹54 Cr |
| Mar2025 | ₹47 Cr |
| Mar2024 | ₹38 Cr |
| Mar2023 | ₹33 Cr |
| Mar2022 | ₹99 Cr |
How is Total Current Liabilities of LYKA LABS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹54 Cr | 15.60 | |
| Mar2025 | ₹47 Cr | 23.44 | |
| Mar2024 | ₹38 Cr | 15.87 | |
| Mar2023 | ₹33 Cr | -67.19 | |
| Mar2022 | ₹99 Cr | - | |
Compare Total Current Liabilities of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹304.7 Cr | -3.4% | 12.2% | -17.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹436,679.0 Cr | -1.8% | -7% | 14.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,408.0 Cr | -3.4% | 0.4% | 58.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹182,634.0 Cr | -2.7% | -3.6% | 36% | Stock Analytics | |
| CIPLA | ₹109,063.0 Cr | -3.9% | -4.7% | -10.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,166.0 Cr | 3% | 6.1% | -3.8% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | -3.4% |
12.2% |
-17.4% |
| SENSEX | -3.1% |
-6.2% |
-11.7% |
You may also like the below Video Courses